Why the study?
Does combined treatment with clarithromycin and cisapride lead to pharmacokinetic changes and increased QT intervals in healthy volunteers?
Population
12 healthy volunteers
Comparison
Cisapride for 10 days with concomitant… vs Baseline and monotherapy with either cisapride…
Design
RCT, randomized, 2-way crossover, open
Follow-up
10 days per treatment period
Authors
Loading...
Supports contraindication of cisapride-clarithromycin coadministration; confirms case-report signals with RCT evidence of QTc and pharmacokinetic effects.
Does combined treatment with clarithromycin and cisapride lead to pharmacokinetic changes and increased QT intervals in healthy volunteers?
Coadministration of cisapride and clarithromycin produces substantial QT prolongation and increases cisapride concentrations, supporting the contraindication to combine these drugs.
Haarst et al. (1998) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: